Exact Mass: 290.163

Exact Mass Matches: 290.163

Found 99 metabolites which its exact mass value is equals to given mass value 290.163, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Procaterol

8-hydroxy-5-[(1R,2S)-1-hydroxy-2-[(propan-2-yl)amino]butyl]-1,2-dihydroquinolin-2-one

C16H22N2O3 (290.163)


Procaterol is only found in individuals that have used or taken this drug. It is a long-acting beta-2-adrenergic receptor agonist. It is a potent bronchodilator that may be administered orally or by aerosol inhalation. [PubChem]Beta(2)-receptor stimulation in the lung causes relaxation of bronchial smooth muscle, bronchodilation, and increased bronchial airflow. R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03C - Adrenergics for systemic use > R03CC - Selective beta-2-adrenoreceptor agonists R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AC - Selective beta-2-adrenoreceptor agonists D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists

   

1-Octen-3-yl glucoside

2-(hydroxymethyl)-6-(oct-1-en-3-yloxy)oxane-3,4,5-triol

C14H26O6 (290.1729)


1-Octen-3-yl glucoside is found in herbs and spices. 1-Octen-3-yl glucoside is a constituent of spearmint (Mentha spicata var. crispa). Constituent of spearmint (Mentha spicata variety crispa). 1-Octen-3-yl glucoside is found in herbs and spices.

   

Diisopentyl thiomalate

1,4-bis(3-methylbutyl) 2-sulfanylbutanedioate

C14H26O4S (290.1552)


Diisopentyl thiomalate is used as a food additive [EAFUS] ("EAFUS: Everything Added to Food in the United States. [http://www.eafus.com/]")

   

O-Adipoylcarnitine

(3R)-3-[(5-carboxypentanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C13H24NO6 (290.1604)


O-Adipoylcarnitine is an acylcarnitine. More specifically, it is an adipic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy.  This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. O-Adipoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine O-adipoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

16alpha-Fluoroestradiol

16-Fluoro-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol

C18H23FO2 (290.1682)


   

4-Fluoroestradiol

6-fluoro-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2(7),3,5-triene-5,14-diol

C18H23FO2 (290.1682)


   

Methyl 4-[(propionyl)phenylamino]piperidine-4-carboxylate

Methyl 4-[(propionyl)phenylamino]piperidine-4-carboxylic acid

C16H22N2O3 (290.163)


   

Fluoroestradiol F18

(1S,10R,11S,13R,14R,15S)-13-(¹⁸F)fluoro-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2(7),3,5-triene-5,14-diol

C18H23FO2 (290.1682)


   
   

Maybridge4_003684

Maybridge4_003684

C16H22N2O3 (290.163)


   

(-)-Geneserine

(-)-Geneserine

C16H22N2O3 (290.163)


   
   
   

glycylseryllysine

glycylseryllysine

C11H22N4O5 (290.159)


   
   

serylglycyllysine

serylglycyllysine

C11H22N4O5 (290.159)


   
   

C16H22N2O3_4,6,8-Decatrienamide, 3-hydroxy-2,2,4-trimethyl-10-(5-oxazolyl)-, (3R,4Z,6Z,8E)

NCGC00380954-01_C16H22N2O3_4,6,8-Decatrienamide, 3-hydroxy-2,2,4-trimethyl-10-(5-oxazolyl)-, (3R,4Z,6Z,8E)-

C16H22N2O3 (290.163)


   
   
   
   

(R,S)-Procaterol

8-hydroxy-5-[(1R,2S)-1-hydroxy-2-[(propan-2-yl)amino]butyl]-1,2-dihydroquinolin-2-one

C16H22N2O3 (290.163)


R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03C - Adrenergics for systemic use > R03CC - Selective beta-2-adrenoreceptor agonists R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AC - Selective beta-2-adrenoreceptor agonists D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists

   

WZ811

N1,N4-di-2-pyridinyl-1,4-benzenedimethanamine

C18H18N4 (290.1531)


   

diisoamyl thiomalate

1,4-bis(3-methylbutyl) 2-sulfanylbutanedioate

C14H26O4S (290.1552)


   

Ethyl orthoacetate

2-(hydroxymethyl)-6-(oct-1-en-3-yloxy)oxane-3,4,5-triol

C14H26O6 (290.1729)


   

ascr#14

7R-(3R,5R-dihydroxy-6S-methyl-(2H)-tetrahydropyran-2-yloxy)-octanoic acid

C14H26O6 (290.1729)


An (omega-1)-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (7R)-7-hydroxyoctanoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.

   

oscr#14

8-(3R,5R-dihydroxy-6S-methyl-(2H)-tetrahydropyran-2-yloxy)-octanoic acid

C14H26O6 (290.1729)


An omega-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of 8-hydroxyoctanoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.

   

4-(4-BENZYL-1,4-DIAZEPAN-1-YL)-4-OXOBUTANOICACID

4-(4-BENZYL-1,4-DIAZEPAN-1-YL)-4-OXOBUTANOICACID

C16H22N2O3 (290.163)


   

8,8-Diphenyl-2,3,4,8-tetrahydroimidazo[1,5-a]pyrimidin-6-amine

8,8-Diphenyl-2,3,4,8-tetrahydroimidazo[1,5-a]pyrimidin-6-amine

C18H18N4 (290.1531)


   

N-alpha-Boc-L-tryptophanol

N-alpha-Boc-L-tryptophanol

C16H22N2O3 (290.163)


   

1(2H)-Quinolinecarboxylic acid, 3-(acetylamino)-3,4-dihydro-, 1,1-dimethylethyl ester

1(2H)-Quinolinecarboxylic acid, 3-(acetylamino)-3,4-dihydro-, 1,1-dimethylethyl ester

C16H22N2O3 (290.163)


   

1-Boc-4-(4-Formylphenyl)piperazine

1-Boc-4-(4-Formylphenyl)piperazine

C16H22N2O3 (290.163)


   

(E)-2-(3,5-Dimethoxystyryl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

(E)-2-(3,5-Dimethoxystyryl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

C16H23BO4 (290.1689)


   

(3S)-1,3-DIOXANE-2-METHYL-4-CARBOXYLICACID

(3S)-1,3-DIOXANE-2-METHYL-4-CARBOXYLICACID

C16H22N2O3 (290.163)


   

TERT-BUTYL 1H-SPIRO[FURO[3,4-C]PYRIDINE-3,4-PIPERIDINE]-1-CARBOXYLATE

TERT-BUTYL 1H-SPIRO[FURO[3,4-C]PYRIDINE-3,4-PIPERIDINE]-1-CARBOXYLATE

C16H22N2O3 (290.163)


   
   

5-Amino-3-(1-naphthyl)-4-cyano-1-tert-butylpyrazole

5-Amino-3-(1-naphthyl)-4-cyano-1-tert-butylpyrazole

C18H18N4 (290.1531)


   

1-Bromopentadecane

1-Bromopentadecane

C15H31Br (290.1609)


   

N-t-BOC-D-Tryptophanol

N-t-BOC-D-Tryptophanol

C16H22N2O3 (290.163)


   

5-tert-butyl-2-[(4-fluorophenyl)methyl]pyrazole-3-carbohydrazide

5-tert-butyl-2-[(4-fluorophenyl)methyl]pyrazole-3-carbohydrazide

C15H19FN4O (290.1543)


   

Bis(2-ethoxyethyl) adipate

Bis(2-ethoxyethyl) adipate

C14H26O6 (290.1729)


   

Ethyl piperidinoacetylaminobenzoate

Ethyl piperidinoacetylaminobenzoate

C16H22N2O3 (290.163)


C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent

   

6-Cbz-2,2-dimethylhexahydropyrrolo[3,4-d]-1,3-oxazine

6-Cbz-2,2-dimethylhexahydropyrrolo[3,4-d]-1,3-oxazine

C16H22N2O3 (290.163)


   

4-BENZYL-3-OXOPIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

4-BENZYL-3-OXOPIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C16H22N2O3 (290.163)


   

2,3-Dimesityl-2-cyclopropen-1-one

2,3-Dimesityl-2-cyclopropen-1-one

C21H22O (290.1671)


   

Ethyl 2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate

Ethyl 2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate

C16H23BO4 (290.1689)


   

3-(Triethoxysilyl)propyl methacrylate

3-(Triethoxysilyl)propyl methacrylate

C13H26O5Si (290.1549)


   

Dihydro-1-((4-butoxyphenyl)methyl)-5-methyl-2,4(1H,3H)-pyrimidinedione

Dihydro-1-((4-butoxyphenyl)methyl)-5-methyl-2,4(1H,3H)-pyrimidinedione

C16H22N2O3 (290.163)


   

(S)-1-PYRROLIDIN-2-BENZYL-2-(N-CBZ-N-METHYL)AMINO-ETHANE

(S)-1-PYRROLIDIN-2-BENZYL-2-(N-CBZ-N-METHYL)AMINO-ETHANE

C16H22N2O3 (290.163)


   

4-(2-PIPERIDIN-1-YL-PHENYLCARBAMOYL)BUTYRIC ACID

4-(2-PIPERIDIN-1-YL-PHENYLCARBAMOYL)BUTYRIC ACID

C16H22N2O3 (290.163)


   

(R)-1-Phenylbutylamine

(R)-1-Phenylbutylamine

C16H22N2O3 (290.163)


   

4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]butanoic acid

4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]butanoic acid

C16H23BO4 (290.1689)


   

Tris(4-Aminophenyl)amine

Tris(4-Aminophenyl)amine

C18H18N4 (290.1531)


   

2-tert-butyl-6-[(2-methylpropan-2-yl)oxy]-5-nitro-1H-indole

2-tert-butyl-6-[(2-methylpropan-2-yl)oxy]-5-nitro-1H-indole

C16H22N2O3 (290.163)


   

Tris(2-pyridylmethyl)amine

Tris(2-pyridylmethyl)amine

C18H18N4 (290.1531)


   

methyl 3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]propanoate

methyl 3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]propanoate

C16H23BO4 (290.1689)


   

7-Methyl-2-propyl-2,5-bi-1H-benzimidazole

7-Methyl-2-propyl-2,5-bi-1H-benzimidazole

C18H18N4 (290.1531)


   

(3aR,5R,6S,6aR)-5-(2-hydroxy-3-(trimethylsilyl)propyl)-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-6-ol

(3aR,5R,6S,6aR)-5-(2-hydroxy-3-(trimethylsilyl)propyl)-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-6-ol

C13H26O5Si (290.1549)


   

1-Boc-4-(2-Formylphenyl)piperazine

1-Boc-4-(2-Formylphenyl)piperazine

C16H22N2O3 (290.163)


   

Ethyl 3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate

Ethyl 3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate

C16H23BO4 (290.1689)


   

Fluoroestradiol F-18

Fluoroestradiol F-18

C18H23FO2 (290.1682)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones V - Various > V09 - Diagnostic radiopharmaceuticals > V09I - Tumour detection C1446 - Radiopharmaceutical Compound > C2124 - Radioconjugate

   

Phenbenzamine hydrochloride

Phenbenzamine hydrochloride

C17H23ClN2 (290.155)


   

(7R)-7-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]octanoic acid

(7R)-7-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]octanoic acid

C14H26O6 (290.1729)


   

8-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]octanoic acid

8-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]octanoic acid

C14H26O6 (290.1729)


   

2-(4-Phenyl-1-piperazinyl)quinoxaline

2-(4-Phenyl-1-piperazinyl)quinoxaline

C18H18N4 (290.1531)


   

5-Amino-3-(1-naphthalenylmethyl)-1-propan-2-yl-4-pyrazolecarbonitrile

5-Amino-3-(1-naphthalenylmethyl)-1-propan-2-yl-4-pyrazolecarbonitrile

C18H18N4 (290.1531)


   

[(2R)-3-carboxy-2-(5-carboxypentanoyloxy)propyl]-trimethylazanium

[(2R)-3-carboxy-2-(5-carboxypentanoyloxy)propyl]-trimethylazanium

C13H24NO6+ (290.1604)


   

[3-Carboxy-2-(5-carboxypentanoyloxy)propyl]-trimethylazanium

[3-Carboxy-2-(5-carboxypentanoyloxy)propyl]-trimethylazanium

C13H24NO6+ (290.1604)


   

[3-Carboxy-2-(4-ethoxy-4-oxobutanoyl)oxypropyl]-trimethylazanium

[3-Carboxy-2-(4-ethoxy-4-oxobutanoyl)oxypropyl]-trimethylazanium

C13H24NO6+ (290.1604)


   

[(2R)-3-carboxy-2-[(3R)-4-carboxy-3-methylbutanoyl]oxypropyl]-trimethylazanium

[(2R)-3-carboxy-2-[(3R)-4-carboxy-3-methylbutanoyl]oxypropyl]-trimethylazanium

C13H24NO6+ (290.1604)


   

4-[[1-Azepanyl(oxo)methyl]amino]benzoic acid ethyl ester

4-[[1-Azepanyl(oxo)methyl]amino]benzoic acid ethyl ester

C16H22N2O3 (290.163)


   

Ethyl 1-(4-acetyl-2-aminophenyl)piperidine-4-carboxylate

Ethyl 1-(4-acetyl-2-aminophenyl)piperidine-4-carboxylate

C16H22N2O3 (290.163)


   
   
   
   
   
   
   

3-carboxy-2-[(4-carboxy-3-methylbutanoyl)oxy]-N,N,N-trimethylpropan-1-aminium

3-carboxy-2-[(4-carboxy-3-methylbutanoyl)oxy]-N,N,N-trimethylpropan-1-aminium

C13H24NO6+ (290.1604)


   

[(2R)-3-carboxy-2-(4-carboxy-3-methylbutanoyl)oxypropyl]-trimethylazanium

[(2R)-3-carboxy-2-(4-carboxy-3-methylbutanoyl)oxypropyl]-trimethylazanium

C13H24NO6+ (290.1604)


   
   

6-Benzyloxy-3-methylene-5-(trimethylsilyloxy)-1-hexene

6-Benzyloxy-3-methylene-5-(trimethylsilyloxy)-1-hexene

C17H26O2Si (290.1702)


   

6-Benzyloxymethyl-4-(trimethylsilylmethyl)-5,6-dihydro-2H-pyran

6-Benzyloxymethyl-4-(trimethylsilylmethyl)-5,6-dihydro-2H-pyran

C17H26O2Si (290.1702)


   

1-octen-3-yl glucoside

1-octen-3-yl glucoside

C14H26O6 (290.1729)


   

(3s,6r)-6-benzyl-5-hydroxy-3-[(2r,3r)-3-hydroxybutan-2-yl]-1-methyl-3,6-dihydropyrazin-2-one

(3s,6r)-6-benzyl-5-hydroxy-3-[(2r,3r)-3-hydroxybutan-2-yl]-1-methyl-3,6-dihydropyrazin-2-one

C16H22N2O3 (290.163)


   

(3r,4z,6z,8e)-3-hydroxy-2,2,4-trimethyl-10-(1,3-oxazol-5-yl)deca-4,6,8-trienimidic acid

(3r,4z,6z,8e)-3-hydroxy-2,2,4-trimethyl-10-(1,3-oxazol-5-yl)deca-4,6,8-trienimidic acid

C16H22N2O3 (290.163)


   

2-chloro-4-isopropyl-1,6,6-trimethyl-tetrahydro-2h-indene-1,3a,7a-triol

2-chloro-4-isopropyl-1,6,6-trimethyl-tetrahydro-2h-indene-1,3a,7a-triol

C15H27ClO3 (290.1649)


   

(3s,5s,6s)-2-(hydroxymethyl)-6-(oct-1-en-3-yloxy)oxane-3,4,5-triol

(3s,5s,6s)-2-(hydroxymethyl)-6-(oct-1-en-3-yloxy)oxane-3,4,5-triol

C14H26O6 (290.1729)


   

3-hydroxy-2,2,4-trimethyl-10-(1,3-oxazol-5-yl)deca-4,6,8-trienimidic acid

3-hydroxy-2,2,4-trimethyl-10-(1,3-oxazol-5-yl)deca-4,6,8-trienimidic acid

C16H22N2O3 (290.163)


   

(3r,4z,6e,8e)-3-hydroxy-2,2,4-trimethyl-10-(1,3-oxazol-5-yl)deca-4,6,8-trienimidic acid

(3r,4z,6e,8e)-3-hydroxy-2,2,4-trimethyl-10-(1,3-oxazol-5-yl)deca-4,6,8-trienimidic acid

C16H22N2O3 (290.163)


   

(4e,6e,8e)-3-hydroxy-2,2,4-trimethyl-10-(1,3-oxazol-5-yl)deca-4,6,8-trienimidic acid

(4e,6e,8e)-3-hydroxy-2,2,4-trimethyl-10-(1,3-oxazol-5-yl)deca-4,6,8-trienimidic acid

C16H22N2O3 (290.163)


   

6-benzyl-5-hydroxy-3-(3-hydroxybutan-2-yl)-1-methyl-3,6-dihydropyrazin-2-one

6-benzyl-5-hydroxy-3-(3-hydroxybutan-2-yl)-1-methyl-3,6-dihydropyrazin-2-one

C16H22N2O3 (290.163)


   

(3s,4z,6e,8e)-3-hydroxy-2,2,4-trimethyl-10-(1,3-oxazol-5-yl)deca-4,6,8-trienimidic acid

(3s,4z,6e,8e)-3-hydroxy-2,2,4-trimethyl-10-(1,3-oxazol-5-yl)deca-4,6,8-trienimidic acid

C16H22N2O3 (290.163)


   

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[(3r)-oct-1-en-3-yloxy]oxane-3,4,5-triol

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[(3r)-oct-1-en-3-yloxy]oxane-3,4,5-triol

C14H26O6 (290.1729)


   

n-{1-[2-(hydroxymethyl)pyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl}ethanimidic acid

n-{1-[2-(hydroxymethyl)pyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl}ethanimidic acid

C16H22N2O3 (290.163)


   

(4z,6z,8e)-3-hydroxy-2,2,4-trimethyl-10-(1,3-oxazol-5-yl)deca-4,6,8-trienimidic acid

(4z,6z,8e)-3-hydroxy-2,2,4-trimethyl-10-(1,3-oxazol-5-yl)deca-4,6,8-trienimidic acid

C16H22N2O3 (290.163)


   

(3s,4z,6z,8e)-3-hydroxy-2,2,4-trimethyl-10-(1,3-oxazol-5-yl)deca-4,6,8-trienimidic acid

(3s,4z,6z,8e)-3-hydroxy-2,2,4-trimethyl-10-(1,3-oxazol-5-yl)deca-4,6,8-trienimidic acid

C16H22N2O3 (290.163)


   

n-[(2s)-1-[(2s)-2-(hydroxymethyl)pyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]ethanimidic acid

n-[(2s)-1-[(2s)-2-(hydroxymethyl)pyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]ethanimidic acid

C16H22N2O3 (290.163)


   

(8e)-3-hydroxy-2,2,4-trimethyl-10-(1,3-oxazol-5-yl)deca-4,6,8-trienimidic acid

(8e)-3-hydroxy-2,2,4-trimethyl-10-(1,3-oxazol-5-yl)deca-4,6,8-trienimidic acid

C16H22N2O3 (290.163)